51
45
Growth Score 51 in past quarter
-14 pts
Heat Score 45 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
383818
MicroGenDX provides next-generation DNA sequencing (NGS) for clinical diagnostics.
- Rick Martin: CEO
- Randall Wolcott: Founder
About the Company
MicroGenDX provides next-generation DNA sequencing (NGS) for clinical diagnostics. MicroGenDX has become the industry leader in rapid turnaround and affordability for comprehensive Next-generation sequencing (NGS) and qPCR testing for clinical diagnostics. MicroGenDX is CLIA-licensed and CAP-accredited and has been the trusted research partner for
the CDC, U.S. Army, NASA, and the FDA. MicroGenDX has published over 70 clinical trials and is the most experienced molecular diagnostic laboratory with some 1.5 million samples processed. Over 80,000medical professionals rely on MicroGenDX clinical diagnostics MicroGenDX also offers over 30 specialized clinical diagnostic tests for a comprehensive array of medical specialties and infection types.